Track the Ind-Swift Laboratories Limited stock price and the full directors' dealings record of the company, a listed equity based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Ind-Swift Laboratories Limited has published 16 insider filings. Market capitalisation: €13.5bn. The latest transaction was reported on 10 September 2024 (Sale). Among the most active insiders: ANURAG CHATURVEDI. All data is accessible without an account.
16
Insider Decl.
0
Thresholds
€36,415
1 ops.
Buy Volume
€237,905
15 ops.
Sell Volume
10Σ signal
Buys €36,415€237,905 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,058 of 26,211 companies
44.9
score / 100
Value
26
Quality
64
FCF yld-7.4%
Earn yld1.9%
EV/EBITDA26.7x
ROE3.2%
Gross mgn56%
Net mgn6.5%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.